Application 761094

Type
BLA
Sponsor
DOMPE FARMACEUTICI

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761094Oxervatecenegermin-bkbj351(a)Rx2026-10-01

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001OXERVATECENEGERMIN-BKBJSOLUTION;OPHTHALMIC0.002%(20MCG/ML)NoNo

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 ยท 10 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
71981-001OXERVATEcenegermin-bkbjDompBLACurrent
71981-001OXERVATEcenegermin-bkbjDompBLACurrent
71981-001OXERVATEcenegermin-bkbjDompBLACurrent
71981-001OXERVATEcenegermin-bkbjDompBLACurrent
71981-001OXERVATEcenegermin-bkbjDompBLACurrent
71981-020OXERVATEcenegermin-bkbjDompBLACurrent
71981-020OXERVATEcenegermin-bkbjDompBLACurrent
71981-020OXERVATEcenegermin-bkbjDompBLACurrent
71981-020OXERVATEcenegermin-bkbjDompBLACurrent
71981-020OXERVATEcenegermin-bkbjDompBLACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
75909SUPPL 2023-10-24
75908SUPPL 2023-10-24
75896SUPPL 2023-10-24
75895SUPPL 2023-10-24
60761SUPPL2019-10-31
60753SUPPL2019-10-31
55531ORIG2018-09-20
55310ORIG2018-08-24
55276ORIG2018-08-23